AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Firstwordpharma

Published November 10, 2026

UCSF launches large-scale study of psychedelics in the real world - FirstWord Pharma

Read the full story at Firstwordpharma

Most psychedelic experiences don't happen in research labs. To better understand their effects, UC San Francisco scientists are going where the.

Post on X

Share this story

Surfaced by 4 Google Alerts

Psychedelics
LSD
MDMA
Psychedelic press release